Stephens & Co. Initiates Coverage On C4 Therapeutics With Equal-Weight Rating, Announces Price Target of $4
Stephens & Co. Initiates Coverage On C4 Therapeutics With Equal-Weight Rating, Announces Price Target of $4
Stephens & Co. 對c4 therapeutics發起覆蓋，給予持平評級，宣佈目標價爲4美元
Stephens & Co. analyst Sudan Loganathan initiates coverage on C4 Therapeutics (NASDAQ:CCCC) with a Equal-Weight rating and announces Price Target of $4.
Stephens & Co. 分析師蘇丹·洛根納坦對c4 therapeutics（納斯達克:CCCC）啓動了覆蓋，給予了相等權重評級，並宣佈目標價格爲4美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間